Mariluz Araínga

1.4k total citations
25 papers, 885 citations indexed

About

Mariluz Araínga is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Mariluz Araínga has authored 25 papers receiving a total of 885 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Virology, 13 papers in Infectious Diseases and 10 papers in Immunology. Recurrent topics in Mariluz Araínga's work include HIV Research and Treatment (17 papers), HIV/AIDS drug development and treatment (7 papers) and HIV/AIDS Research and Interventions (6 papers). Mariluz Araínga is often cited by papers focused on HIV Research and Treatment (17 papers), HIV/AIDS drug development and treatment (7 papers) and HIV/AIDS Research and Interventions (6 papers). Mariluz Araínga collaborates with scholars based in United States, Japan and France. Mariluz Araínga's co-authors include Howard E. Gendelman, Elizabeth S. Didier, Chie Sugimoto, Marcelo J. Kuroda, Yanhui Cai, Xavier Álvarez, Larisa Y. Poluektova, Santhi Gorantla, Benson Edagwa and Yoko Aida and has published in prestigious journals such as Nature Communications, The Journal of Immunology and PLoS ONE.

In The Last Decade

Mariluz Araínga

25 papers receiving 871 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mariluz Araínga United States 16 408 294 290 219 136 25 885
Benjamin Lepene United States 17 175 0.4× 317 1.1× 156 0.5× 469 2.1× 99 0.7× 27 850
Patrick Hong United States 12 337 0.8× 171 0.6× 218 0.8× 303 1.4× 247 1.8× 17 832
Ming Sun China 16 262 0.6× 258 0.9× 253 0.9× 211 1.0× 117 0.9× 61 813
Jordana Grazziela Alves Coelho-dos-Reis Brazil 16 281 0.7× 121 0.4× 59 0.2× 132 0.6× 191 1.4× 58 649
Robert A. Barclay United States 12 181 0.4× 229 0.8× 254 0.9× 469 2.1× 79 0.6× 18 691
Amadou Diagne United States 10 340 0.8× 470 1.6× 712 2.5× 123 0.6× 192 1.4× 12 928
C.-Y. Ou United States 10 97 0.2× 198 0.7× 229 0.8× 325 1.5× 104 0.8× 12 708
Liqiang Feng China 18 201 0.5× 313 1.1× 95 0.3× 261 1.2× 336 2.5× 54 850
M A Martin United States 14 498 1.2× 291 1.0× 663 2.3× 449 2.1× 341 2.5× 24 1.4k
Rebecca J. Nusbaum United States 10 343 0.8× 215 0.7× 108 0.4× 238 1.1× 210 1.5× 13 750

Countries citing papers authored by Mariluz Araínga

Since Specialization
Citations

This map shows the geographic impact of Mariluz Araínga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mariluz Araínga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mariluz Araínga more than expected).

Fields of papers citing papers by Mariluz Araínga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mariluz Araínga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mariluz Araínga. The network helps show where Mariluz Araínga may publish in the future.

Co-authorship network of co-authors of Mariluz Araínga

This figure shows the co-authorship network connecting the top 25 collaborators of Mariluz Araínga. A scholar is included among the top collaborators of Mariluz Araínga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mariluz Araínga. Mariluz Araínga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Buckley, Maureen, Mariluz Araínga, Laura Maiorino, et al.. (2025). Visualizing lipid nanoparticle trafficking for mRNA vaccine delivery in non-human primates. Molecular Therapy. 33(3). 1105–1117. 12 indexed citations
2.
Bose, Deepanwita, Mariluz Araínga, Muhammad R. Haque, et al.. (2024). TGF-β blockade drives a transitional effector phenotype in T cells reversing SIV latency and decreasing SIV reservoirs in vivo. Nature Communications. 15(1). 1348–1348. 3 indexed citations
3.
Berard, Alicia R., Charlene Miller, Mariluz Araínga, et al.. (2021). Simian Immunodeficiency Virus Susceptibility, Immunology, and Microbiome in the Female Genital Tract of Adolescent Versus Adult Pigtail Macaques. AIDS Research and Human Retroviruses. 37(7). 510–522. 2 indexed citations
4.
Taylor, Roslyn A., Michael D. McRaven, Ann M. Carias, et al.. (2021). Localization of infection in neonatal rhesus macaques after oral viral challenge. PLoS Pathogens. 17(11). e1009855–e1009855. 1 indexed citations
5.
Taylor, Roslyn A., Ann M. Carias, Michael D. McRaven, et al.. (2021). PET/CT targeted tissue sampling reveals virus specific dIgA can alter the distribution and localization of HIV after rectal exposure. PLoS Pathogens. 17(6). e1009632–e1009632. 5 indexed citations
6.
Lindsay, Kevin E., Daryll Vanover, Merrilee Thoresen, et al.. (2020). Aerosol Delivery of Synthetic mRNA to Vaginal Mucosa Leads to Durable Expression of Broadly Neutralizing Antibodies against HIV. Molecular Therapy. 28(3). 805–819. 37 indexed citations
7.
Lindsay, Kevin E., Sushma M. Bhosle, Chiara Zurla, et al.. (2019). Visualization of early events in mRNA vaccine delivery in non-human primates via PET–CT and near-infrared imaging. Nature Biomedical Engineering. 3(5). 371–380. 144 indexed citations
8.
Zhou, Tianhua, Zhiyi Lin, James R. Hilaire, et al.. (2018). Optimizing the Preparation and Stability of Decorated Antiretroviral Drug Nanocrystals. Nanomedicine. 13(8). 871–885. 21 indexed citations
9.
Hägglund, Sara, Katarina Näslund, Sara Bergström Lind, et al.. (2017). Proteome analysis of bronchoalveolar lavage from calves infected with bovine respiratory syncytial virus—Insights in pathogenesis and perspectives for new treatments. PLoS ONE. 12(10). e0186594–e0186594. 25 indexed citations
10.
Araínga, Mariluz, Benson Edagwa, R. Lee Mosley, et al.. (2017). A mature macrophage is a principal HIV-1 cellular reservoir in humanized mice after treatment with long acting antiretroviral therapy. Retrovirology. 14(1). 17–17. 80 indexed citations
11.
Guo, Dongwei, Tianhua Zhou, Mariluz Araínga, et al.. (2016). Creation of a Long-Acting Nanoformulated 2′,3′-Dideoxy-3′-Thiacytidine. JAIDS Journal of Acquired Immune Deficiency Syndromes. 74(3). e75–e83. 38 indexed citations
12.
Polat, Meripet, Shin‐nosuke Takeshima, Kazuyoshi Hosomichi, et al.. (2016). A new genotype of bovine leukemia virus in South America identified by NGS-based whole genome sequencing and molecular evolutionary genetic analysis. Retrovirology. 13(1). 4–4. 93 indexed citations
13.
Araínga, Mariluz, Hang Su, Larisa Y. Poluektova, Santhi Gorantla, & Howard E. Gendelman. (2016). HIV-1 cellular and tissue replication patterns in infected humanized mice. Scientific Reports. 6(1). 23513–23513. 50 indexed citations
14.
Araínga, Mariluz, et al.. (2015). Opposing regulation of endolysosomal pathways by long-acting nanoformulated antiretroviral therapy and HIV-1 in human macrophages. Retrovirology. 12(1). 5–5. 29 indexed citations
15.
Araínga, Mariluz, Prasanta K. Dash, R. Lee Mosley, et al.. (2015). Pharmacodynamics of folic acid receptor targeted antiretroviral nanotherapy in HIV-1-infected humanized mice. Antiviral Research. 120. 85–88. 18 indexed citations
16.
Araínga, Mariluz, et al.. (2015). Cellular Responses and Tissue Depots for Nanoformulated Antiretroviral Therapy. PLoS ONE. 10(12). e0145966–e0145966. 12 indexed citations
17.
Zhang, Gang, Dongwei Guo, Prasanta K. Dash, et al.. (2015). The mixed lineage kinase-3 inhibitor URMC-099 improves therapeutic outcomes for long-acting antiretroviral therapy. Nanomedicine Nanotechnology Biology and Medicine. 12(1). 109–122. 24 indexed citations
18.
19.
20.
Araínga, Mariluz, et al.. (2010). Phylogenetic Analysis of Classical Swine Fever Virus Isolates from Peru. Transboundary and Emerging Diseases. 57(4). no–no. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Benjamin Lepene Breakdown of academic impact, for papers by Patrick Hong Breakdown of academic impact, for papers by Ming Sun Breakdown of academic impact, for papers by Jordana Grazziela Alves Coelho-dos-Reis Breakdown of academic impact, for papers by Robert A. Barclay Breakdown of academic impact, for papers by Amadou Diagne Breakdown of academic impact, for papers by C.-Y. Ou Breakdown of academic impact, for papers by Liqiang Feng Breakdown of academic impact, for papers by M A Martin Breakdown of academic impact, for papers by Rebecca J. Nusbaum
Rankless by CCL
2026